Administration of dexmedetomidine nebulisation prior will improve the intraoperative hemodynamic status of patients.

Influence of dexmedetomidine nebulisation on isoflurane requirement in patients undergoing entropy guided general anaesthesia- a double blinded randomised control trial. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/096403

Enrollment

Registered

2025-10-23

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: nil: nil Control Intervention1: To compare the hemodynamics in group dexmedetomidine and group NS: Nebulisation dexmedetodine given to group D and nebulisation Ns given to other group C

Eligibility

Inclusion criteria

Inclusion criteria: Patient scheduled for elective surgeries requiring general anaesthesia lasting for less than 2 hours. patients belonging to ASA 1 & 2

Exclusion criteria

Exclusion criteria: patients under going emergency surgeries . Obese individuals (BMI more than 30). patients with known allergy to dexmedetomidine. patients belonging to ASA 3 & 4. Patients with cardiovascular and respiratory disorders.

Design outcomes

Primary

Measure	Time frame
to decrease the consumption of isoflurane consumption in patients receiving dexmedetomidine nebulisation and improve the patient recoveryTimepoint: 72hours	—

Secondary

Measure	Time frame
to decrease the complications & to maintain the hemodynamic statusTimepoint: 72 hours	—

Countries

India

Contacts

Public ContactDrKowsthuba Narayan

S.Nijalingappa medical college and HSK hospital,Bagalkot.

ndrsangamesh@gmail.com9845268463

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026